Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab.

Yasuhito Terui; Takuma Sakurai; Yuko Mishima; Yuji Mishima; Natsuhiko Sugimura; Chino Sasaoka; Kiyotsugu Kojima; Masahiro Yokoyama; Nobuyuki Mizunuma; Shunji Takahashi

doi:10.1111/j.1349-7006.2006.00139.x

Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab.

Identifier:nobleid.org/w1/20260515/EBBEAB2A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EBBEAB2A.svg?ark=w1%2F20260515%2FEBBEAB2A)](https://nobleid.org/work/w1/20260515/EBBEAB2A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab.

Identifier:nobleid.org/w1/20260515/EBBEAB2A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EBBEAB2A.svg?ark=w1%2F20260515%2FEBBEAB2A)](https://nobleid.org/work/w1/20260515/EBBEAB2A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work